GlassScriptPhysician profile
Heather H Lenga
NPI 1477637858
$1,832.38
in general payments reported to CMS, 2019-2025
19 companies · $121 in 2025
The $121 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $440 · 2020: $62.50 · 2021: $228 · 2022: $376 · 2023: $423 · 2024: $182 · 2025: $121.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $726.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $725.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tris Pharma INC | $304.03 | 2019-2025 | Dyanavel Xr |
| Supernus Pharmaceuticals, INC. | $214.58 | 2021-2023 | Qelbree |
| Corium, LLC | $193.74 | 2021-2025 | Azstarys |
| Ironshore Pharmaceuticals INC. | $177.42 | 2019-2024 | Jornay Pm |
| Pfizer INC. | $160.74 | 2019-2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $136.39 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $112.04 | 2023 | Farxiga, Flumist Quadrivalent |
| Sanofi Pasteur INC. | $106.82 | 2019-2025 | |
| Abbvie INC. | $89.75 | 2024 | |
| Merck Sharp & Dohme LLC | $66.82 | 2022-2023 | Vaxneuvance |
| Nestle Healthcare Nutrition INC. | $62.83 | 2021-2023 | |
| Sobi, INC | $51.64 | 2022-2023 | |
| Neos Therapeutics, LP | $47.30 | 2019-2024 | Cotempla Xr-Odt |
| Aimmune Therapeutics, INC. | $24.71 | 2021 | |
| Shire North American Group INC | $22.98 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kaleo, INC. | $18.11 | 2022 | |
| Genentech USA, INC. | $14.98 | 2019 | |
| Seqirus USA INC | $13.93 | 2022 | |
| Alexion Pharmaceuticals, INC. | $13.57 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heather Lenga listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.